G-CSF: a key regulator of neutrophil production, but that's not all!
about
Identification of granulocyte colony-stimulating factor and interleukin-6 as candidate biomarkers of CBLB502 efficacy as a medical radiation countermeasureAlphavirus replicon-based enhancement of mucosal and systemic immunity is linked to the innate response generated by primary immunizationNon-invasive Imaging of Sendai Virus Infection in Pharmacologically Immunocompromised Mice: NK and T Cells, but not Neutrophils, Promote Viral Clearance after Therapy with Cyclophosphamide and DexamethasoneThe Toll-Like Receptor 5 Agonist Entolimod Mitigates Lethal Acute Radiation Syndrome in Non-Human PrimatesProinflammatory chemokines are major mediators of exuberant immune response associated with Influenza A (H1N1) pdm09 virus infection.Soluble prokaryotic overexpression and purification of bioactive human granulocyte colony-stimulating factor by maltose binding protein and protein disulfide isomerase.First-in-human, phase I/IIa dose-escalation and safety study of balugrastim in breast cancer patients receiving myelosuppressive chemotherapy.G-CSF does not influence C2C12 myogenesis despite receptor expression in healthy and dystrophic skeletal muscle.Transplantation of autologous peripheral blood mononuclear cells in the subarachnoid space for amyotrophic lateral sclerosis: a safety analysis of 14 patientsAnti-neutrophil antibody enhances the neuroprotective effects of G-CSF by decreasing number of neutrophils in hypoxic ischemic neonatal rat model.Pharmacokinetic profiles of a biosimilar filgrastim and Amgen filgrastim: results from a randomized, phase I trialMolecular signatures of the evolving immune response in mice following a Bordetella pertussis infection.Conditional inactivation of TACE by a Sox9 promoter leads to osteoporosis and increased granulopoiesis via dysregulation of IL-17 and G-CSF.Early systemic granulocyte-colony stimulating factor treatment attenuates neuropathic pain after peripheral nerve injury.Protein multifunctionality: principles and mechanisms.Granulocyte colony-stimulating factor (G-CSF) protects oligodendrocyte and promotes hindlimb functional recovery after spinal cord injury in rats.Transient neutropenia after granulocyte-colony stimulating factor administration is associated with neutrophil accumulation in pulmonary vasculature.Reduced expression of basal and probiotic-inducible G-CSF in intestinal mononuclear cells is associated with inflammatory bowel disease.SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritis.The effects of p38 MAPK inhibition combined with G-CSF administration on the hematoimmune system in mice with irradiation injury.Cyclophosphamide induces dynamic alterations in the host microenvironments resulting in a Flt3 ligand-dependent expansion of dendritic cells.The tuberculosis vaccine candidate Bacillus Calmette-Guérin ΔureC::hly coexpressing human interleukin-7 or -18 enhances antigen-specific T cell responses in miceDoxorubicin and daunorubicin induce processing and release of interleukin-1β through activation of the NLRP3 inflammasome.G-CSF preferentially supports the generation of gut-homing Gr-1high macrophages in M-CSF-treated bone marrow cells.Human severe sepsis cytokine mixture increases β2-integrin-dependent polymorphonuclear leukocyte adhesion to cerebral microvascular endothelial cells in vitro.Circumventing Y. pestis Virulence by Early Recruitment of Neutrophils to the Lungs during Pneumonic Plague.Neuroprotective therapy using granulocyte colony-stimulating factor for patients with worsening symptoms of compression myelopathy, Part 1: a phase I and IIa clinical trial.Preferential production of G-CSF by a protein-like Lactobacillus rhamnosus GR-1 secretory factor through activating TLR2-dependent signaling events without activation of JNKs.The SOCS box of suppressor of cytokine signaling-3 contributes to the control of G-CSF responsiveness in vivo.Mastitis Pathogens with High Virulence in a Mouse Model Produce a Distinct Cytokine Profile In Vivo.A Combination of Podophyllotoxin and Rutin Attenuates Radiation Induced Gastrointestinal Injury by Negatively Regulating NF-κB/p53 Signaling in Lethally Irradiated Mice.Neuroprotective therapy using granulocyte colony-stimulating factor for acute spinal cord injury: a phase I/IIa clinical trialIntravenous administration of granulocyte colony-stimulating factor for treating neuropathic pain associated with compression myelopathy: a phase I and IIa clinical trial.Reduced neutrophil chemotaxis and infiltration contributes to delayed resolution of cutaneous wound infection with advanced age.Enhanced stability of tristetraprolin mRNA protects mice against immune-mediated inflammatory pathologies.Role of G-CSF in monophosphoryl lipid A-mediated augmentation of neutrophil functions after burn injury.Diabetes impairs stem cell and proangiogenic cell mobilization in humans.Candida albicans-Staphylococcus aureus polymicrobial peritonitis modulates host innate immunity.Immunogenicity Assessment of Lipegfilgrastim in Patients with Breast Cancer Receiving ChemotherapyProphylactic Administration of Vector-Encoded Porcine Granulocyte-Colony Stimulating Factor Reduces Salmonella Shedding, Tonsil Colonization, and Microbiota Alterations of the Gastrointestinal Tract in Salmonella-Challenged Swine
P2860
Q24627006-682C363B-E86C-4AAA-8C3E-D27ACC73B877Q24634730-A96F766F-4537-4B5D-A53D-06F6AE57D94CQ27312086-F55B9A98-41EA-4C34-8173-06800ADED383Q28548012-28EB528F-2F2F-4E7B-9BF8-6D9E3EB778A0Q30398612-B90E2B48-B3D5-42D0-8FE9-9C9FED3BF5CCQ31152401-78F74174-2215-4D2C-A8DD-600A0239AC8EQ33420907-55062679-6DF3-4A05-A339-9EF225A376E9Q33579922-ADD4CBE5-6ADA-4F82-8574-8E45FD518C51Q33588597-E16845D4-61A0-4146-BD6F-52B03C5F9A8FQ33943588-53713DAA-9DC8-495F-830C-55F525A67A79Q34013208-3F076600-2CBC-42F4-A799-BD0AB3857314Q34066406-7D07E7AD-7900-43AA-AC6B-702A0F8ED89EQ34076325-4AEE29DF-88DE-4ABF-893A-39BE269D6B69Q34399299-5E983AE6-25EB-4EE9-88BA-F79AE028EBEEQ34497721-54565CC1-B64B-4F73-B613-D643450BAEC5Q34500255-94A13F5C-AB94-48A9-9437-4C3711F48744Q34516616-767C5B88-245A-4A5B-B89C-6E851C83F1C6Q34601391-E89131B5-717A-43E5-9690-90E1191E951FQ34619592-0E45EA97-F806-4299-9C3C-D70D4A2FDEB1Q34706927-48231176-0B37-4D1B-82FE-B17B028CCD07Q34732294-47519FEF-D6E3-4116-BB14-C14D5ED0375AQ35043659-98BE0B17-3089-4D87-B3D8-CF45DFB88366Q35124414-D4B2A138-DD99-4526-A83A-1C33BD520207Q35198809-9F069648-0421-45BB-86F0-50E242EF39B2Q35537959-F3C93E8C-52F1-4AFC-AABA-789C7C7F53F8Q35606567-F8B26118-F330-42E5-96F2-0D990FFB7327Q35812678-FE601762-D47F-4E24-AB15-BC9D5BB3BD8BQ35821701-38955347-268E-4F87-A0F1-7FB485EAC962Q35989418-425165E4-AA17-44BA-8DBD-BF762D362FEAQ36155967-3ADD3D4E-7269-4A12-A602-8C7F56C7C0FAQ36236345-9A5FFF73-1534-40AF-811F-921DB37EB2C4Q36428437-811F6AB9-EE01-47C0-AC66-2A6DC77962B8Q36518718-4883DF66-8D0B-4436-9DC8-8419ED00D2AAQ36586146-A4004A6D-1B03-404F-BEF2-782935F416B9Q36607631-71F6245B-C9F9-4787-8333-0C6B000AC205Q36676013-12F87B85-8E6F-4717-9726-A3A01AF8F5EAQ36720330-8FC097D1-9BF1-4606-8D37-31DF2D2BCAA3Q36911444-5BE8386A-4DEC-4C18-95A9-C99BCA9F7B2CQ37072872-18B3EAE6-D09F-4103-8E9C-7F69A9BB8032Q37201481-A52A32E2-D5B9-4B8C-80E8-CA3C87C906D2
P2860
G-CSF: a key regulator of neutrophil production, but that's not all!
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
G-CSF: a key regulator of neutrophil production, but that's not all!
@ast
G-CSF: a key regulator of neutrophil production, but that's not all!
@en
type
label
G-CSF: a key regulator of neutrophil production, but that's not all!
@ast
G-CSF: a key regulator of neutrophil production, but that's not all!
@en
prefLabel
G-CSF: a key regulator of neutrophil production, but that's not all!
@ast
G-CSF: a key regulator of neutrophil production, but that's not all!
@en
P1476
G-CSF: a key regulator of neutrophil production, but that's not all!
@en
P356
10.1080/08977190500055836
P577
2005-03-01T00:00:00Z